Related Experiment Video

Updated: Nov 1, 2025

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

2.6K

Mycoplasma pneumoniae co-infection with SARS-CoV-2: A case report

Rama Chaudhry1, K Sreenath1, E V Vinayaraj1

  • 1Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.

Access Microbiology
|June 21, 2021
PubMed

Insights

Severe COVID-19 cases can present with co-infection of SARS-CoV-2 and Mycoplasma pneumoniae. Broader pathogen testing is crucial for accurate diagnosis and timely treatment of severe respiratory infections.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pulmonology

Background:

  • Community-acquired pneumonia (CAP) diagnosis can be challenging due to overlapping symptoms with viral infections.
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can present with atypical bacterial co-infections.
  • Mycoplasma pneumoniae is a common cause of atypical pneumonia.

Observation:

  • A case of co-infection with SARS-CoV-2 and Mycoplasma pneumoniae was identified in a patient with pneumonia in India.
  • Clinical and radiographic features of SARS-CoV-2 and M. pneumoniae can be similar, complicating differential diagnosis.

Findings:

  • Co-infection of SARS-CoV-2 and M. pneumoniae is infrequently reported.
  • This case highlights the importance of considering bacterial co-infections in severe COVID-19.

Implications:

  • Comprehensive testing for common respiratory pathogens is recommended in severe COVID-19 cases.
  • Early identification of co-existing pathogens enables pathogen-directed therapy.
  • Timely diagnosis and treatment of co-infections can improve patient outcomes and save lives during the COVID-19 pandemic.
Keywords:
COVID-19Mycoplasma pneumoniaeco-infectionsinfectionpneumoniatherapy

More Related Videos

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

2.8K
Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice10:47

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice

Published on: April 14, 2011

17.1K

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.4K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
546
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
447
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.8K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
534
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
751